Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

EPO Defers Decision on Appeal Concerning BioPorto A/S’ NGAL Cutoff Patent EP1831699

Tuesday, 15 Oct 2013 01:12pm EDT 

BioPorto A/S announced that following a hearing in the NGAL cutoff opposition proceedings that took place on October 15, 2013, the European Patent Organization (EPO) has exceptionally chosen not to reach a final decision. The proceedings will be continued on the basis of written submissions. BioPorto has not received information about the timing of further proceedings. BioPorto’s patent remains fully valid during the proceedings. 

Related Company News

Company Quote

-0.04 -2.17%
23 Dec 2014